This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its spirocyclic structure makes it a valuable building block for developing compounds with potential therapeutic effects, particularly in the field of central nervous system (CNS) disorders. It has been explored for its role in creating molecules that target receptors or enzymes involved in neurological conditions, such as anxiety, depression, and neurodegenerative diseases. Additionally, its unique structural properties make it a candidate for drug discovery programs aimed at identifying novel treatments with improved efficacy and safety profiles. Researchers also investigate its potential in designing ligands for specific biological targets, contributing to advancements in medicinal chemistry.